Home walking programs delivered online or by telehealth for veterans with peripheral artery disease
Compares two remote home walking programs for veterans with peripheral artery disease.
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- Aurora, Birmingham, and Palo Alto, United StatesSee the 3 sites
- Trial code
- Registry title
- Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease
- Status
- Recruiting
- People taking part
- 225 people, planned
- Started
- 1 Jul 2024
- Expected to end
- 29 Oct 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- Walking Program: Internet-based
- Walking Program: Telehealth-based
- Record updated
- 6 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with peripheral artery disease in the legs who get leg pain when walking and are not very active. It compares home walking programs given online or by telehealth with usual care.
- Age
- 21 years and older
- Sex
- Men and women
- Disease stage
- Lower leg artery disease caused by hardened, narrowed arteries (atherosclerosis), with leg pain when walking (claudication) at stage 1-3 on the Rutherford Scale. People must be able to walk at least one city block.
- Earlier treatment
- People must not have recently joined an exercise program. They must do less than 150 minutes per week of physical activity. They need medical clearance from their primary care or vascular care provider.
Main reasons for not taking part
- Expected to live less than six months, or other illnesses that severely limit walking (for example needing a wheelchair)
- Planned surgery to restore blood flow (revascularization) or amputation in the next two months
- Heart or brain blood vessel event in the last 3 months, such as stroke, TIA, heart attack, unstable angina, stent or bypass surgery
- Unstable heart conditions, such as severe valve disease, NYHA class III-IV heart failure or complex heart rhythm problems
- Living in a nursing home, pregnancy, current substance abuse, or unable to speak and read English
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Men and women
- Diagnosis of lower extremity PAD due to atherosclerosis
- Claudication with walking defined as stage 1-3 on the Rutherford Scale
- Medical clearance from the patient's primary care provider or vascular care provider
- Ability to walk at least one city block
- Self-reported sedentary behaviors defined as < 150 minutes per week of physical activity
- Access to a phone and/or email \& Internet
- Competent to provide informed consent
Who cannot take part
- Recent CVD events (< 3 months) including stroke/TIA, MI, UA, PCI/CABG
- Unstable cardiac conditions (severe valve disease, NYHA class III-IV heart failure, untreated complex congenital heart disease, or complex arrhythmias)
- Psychiatric disorder which limits the patient's ability to follow the study protocol
- Life expectancy of less than six months
- Comorbidities that limit walking to a severe degree (i.e., wheelchair-bound)
- Resident of a nursing home
- Recent enrollment in an exercise program or performing 150 minutes per week or more of exercise
- Planned revascularization or amputation in the next two months
- Current substance abuse
- Pregnancy
- Inability to speak and read English
Where in United States
- Rocky Mountain Regional VA Medical Center, Aurora, COAurora, United StatesContact: Kamal Henderson, MDNot yet recruiting
- Birmingham VA Medical Center, Birmingham, ALBirmingham, United StatesContact: Megan A Baker, BSNot yet recruiting
- VA Palo Alto Health Care System, Palo Alto, CAPalo Alto, United StatesContact: Jonathan N Myers, PhDTaking people
About the trial
What the trial wants to find out
Walking is beneficial for adults with peripheral arterial disease. Benefits include the ability to walk for longer periods and general well being (quality of life). This study will look at two types of delivery methods for a home-based walking program. The walking program includes step count goals, information on healthy walking and motivational messages. The two delivery methods include a web-based delivery and an telehealth delivery. Participants are randomized to either one of the delivery methods or usual care. After 12 weeks participants in the web based or telehealth based groups maybe re-randomized to receive a combination of both web-based and telehealth for a second 12 week period. After 24 weeks, everyone is followed for an additional 12 weeks, so the total time a participant is in the study is 36 weeks. At baseline, 12, 24 and 36 weeks the investigators ask participant to walk (slowly) on a treadmill, perform a six-minute walk test, and several questionnaires on quality of life. Vouchers are provided at each study visit. All participants who complete the study also keep their pedometer.
The 2 groups in the trial
- Internet-based Walking ProgramTreatment being tested
Internet pages allow participants to see step-count goals, progress over time and access to walking tips
Treatment: Walking Program: Internet-based
- Telehealth Counseling Walking ProgramTreatment being tested
Telehealth sessions allow participants review step-count goals, progress over time and access to walking tips with the study coordinator
Treatment: Walking Program: Telehealth-based
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease (TREK-PAD)
- Plain-language title
- Home walking programs delivered online or by telehealth for veterans with peripheral artery diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 6 May 2026